Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US7098027

Title:Method for remyelinating a demyelinized lesion due to injury in the brain or spinal cord
Inventors:Honmou, Osamu; Hokkaido, Japan
Hashi, Kazuo; Hokkaido, Japan
Uede, Teiji; Hokkaido, Japan
Summary:This invention describes a method of remyelinating a demyelinated lesion due to injury in the brain or spinal cord of a patient, with a cell fraction containing cells that are capable of differentiating into nervous system cells. Results are provided for demyelinated axons that were remyelinated in a demyelinated rat model by collecting bone marrow cells from mouse bone marrow and transplanting the mononuclear cell fraction separated from these bone marrow cells. Recommended methods of treatment for human patients are also detailed. Provided are means of obtaining the bone marrow, diluting and centrifuging the cells, separating, collecting and suspending the mononuclear cell fraction, removing the supernatant, and administering the cell fraction to the patient. After injection into the patient, the mononuclear cell fraction migrates to the location of demyelinated neural tissue, where it differentiates into neural cells and forms myelinated axons in the demyelinated lesion approximately three weeks after injection.
Abstract:Demyelinated axons were remyelinated in the demyelinated rat model by collecting bone marrow cells from mouse bone marrow and transplanting the mononuclear cell fraction separated from these bone marrow cells.
US Patent Website:Click Here for Full Text of Patent
Title Number:US7098027
Application Number:US2002000330963
Date Filed:23/12/2002
Date Published:29/08/2006
Assignee:Renomedix Institute, Inc., Hokkaido, Japan


 
Copyright © 2007 The Institute for Cellular Medicine  6/18/2021